z-logo
open-access-imgOpen Access
Onabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Injury
Author(s) -
Yan Li,
Aleksandra Grobelna
Publication year - 2021
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2021.61
Subject(s) - spasticity , traumatic brain injury , medicine , guideline , botulinum toxin , physical medicine and rehabilitation , anesthesia , psychiatry , pathology
No relevant literature was identified regarding the clinical effectiveness or cost-effectiveness of onabotulinum toxin A (Botox) for reducing spasticity in patients with traumatic or non-traumatic–acquired brain injury. Authors of 1 evidence-based guideline recommend the use of botulinum toxin (subtype and formulation not specified) for the treatment of spasticity associated with traumatic brain injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here